Join our Keck Graduate Institute (KGI) community as we share behind-the-scenes insights on the innovation and collaboration taking place on campus. On this podcast, we share conversations with students, faculty, staff, alumni, and other guests. Visit our website at kgi.edu and follow us on social media @KeckGrad.
#140 - Mimi Nguyen: Industry Talk
In this Industry Talk, we speak with Mimi Nguyen, a Regulatory Health Project Manager in the Office of Strategic Partnerships and Technology Innovation in the Center for Devices and Radiological Health at the U.S. Food and Drug Administration. She helps manage and organize strategic initiatives, pilot projects, and cross-cutting working groups. Additionally, Nguyen has done work in technology transfer, strategic planning, and program building.
Nguyen received a Bachelor of Science in Biochemistry and Cell Biology from the University of California, San Diego, and a Master of Business and Science with a focus in Clinical and Regulatory Affairs from KGI.
#139 - Zach Myers: Industry Talk
In this Industry Talk, Zach Myers, JD, Partner at Wilson Sonsini, talks about formation, financing trends, and strategies for life sciences companies. He has been recognized as a “go-to” attorney for Southern California’s private and public companies in the technology and life sciences sectors—especially biotechnology and medical device companies—in complex, high-value transactions.
Myers’ practice allows him to work with startups to large public clients. He represents private companies connected with university spin-outs and venture capital financings, helping companies raise millions of dollars needed to fund, grow, and expand their businesses. He has assisted numerous clients that have gone public, listing on the New York Stock Exchange and NASDAQ markets. Notably, Myers has represented some of Southern California’s hottest and most successful companies from formation, through venture capital financings, to initial public offerings, and through sales.
#138 - Allyson Berent: Industry Talk
In this industry talk, Dr. Allyson Berent talks about "A Parent’s Journey Through Drug Development and Wearing Many Hats". Berent is the Chief Science Officer for the Foundation for Angelman Syndrome Therapeutics and the Chief Operating Officer for GeneTx Biotherapeutics, developing a novel antisense olignonucleotide for the treatment of Angelman syndrome, asrare neurogenetic disorder.
Berent graduated from Cornell University College of Veterinary Medicine in 2002 and completed a residency in veterinary internal medicine at the University of Pennsylvania in 2005, followed by a fellowship in interventional radiology and endourology at the University of Pennsylvania and Thomas Jefferson University. Since 2009, Berent serves as the Director of Interventional Endoscopy Services at the Animal Medical Center in New York City.
#137 - Lori Westin: Industry Talk
In this industry talk, we hear from Lori Westin, Partner at Wilson Sonsini, as she discusses intellectual property and patent strategies for the emerging growth company.
Westin possesses a PhD in Biology from Boston University and a JD from the Thomas Jefferson School of Law. She has extensive experience that includes serving as a senior research scientist in Advanced Technologies at Nanogen, Inc.; a research associate in the Regulatory Biology Laboratory at the Salk Institute; and a postdoctoral fellow in the Laboratory of Molecular Genetics, CMB, at the Karolinska Institute in Sweden.
She is the primary author of numerous scientific and legal publications and is an inventor on seven issued U.S. patents on microchips and DNA amplification technology. Westin is a Partner at Wilson Sonsini, where she focuses on intellectual property, life sciences, litigation, patent litigation, patents and innovations, and post-grant reviews.
#136 - Joel West Surpasses 20,000 Citations on Google Scholar
In this episode, we talk with KGI Professor of Innovation and Entrepreneurship Dr. Joel West. In January of 2022, West surpassed 20,000 citations on Google Scholar for his research on Open Innovation.
Open innovation is the practice of a company opening its research and development department to opinions and ideas within, and outside, the organization. This practice is supposed to help break down the traditional silos between researchers, experts, and departments.
#135 - Chris Garabedian: Industry Talk
In this industry talk, Chris Garabedian, Chairman and CEO of Xontogeny LLC, discusses his career and gives advice to KGI students.
Since 2009, Garabedian has been one of KGI’s most engaged champions. He currently serves on the Executive Committee of the KGI Corporate Relations Board, has sponsored multiple TMPs, and has hired several KGI alumni.
Garabedian has a robust track record of leadership in industry, including serving as CEO of Sarepta Therapeutics prior to founding biotech accelerator Xontogeny. As evidenced by his multiple board appointments, he is a sought-after expert and has a prolific record for contributing to companies and organizations to support the advancement of science and the development of the biotech industry.
Hear about amazing things happening at the institute as well as interesting developments in the health sciences and biotech industries.
This podcast is a fantastic cross representation of our community of both internal and external stakeholders! #innovatorsstarthere